Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy
Pamela A. Frischmeyer‐GuerrerioNational Institute of Allergy and Infectious DiseasesMadhan MasilamaniDepartment of Pediatrics, Division of Allergy & Immunology, Icahn School of Medicine at Mount Sinai, New York, NYWenjuan GuLeidos Biomedical Research Inc. (United States)Erica BrittainBiostatistics Research Branch, Division of Clinical Research, National Institutes of Health, Bethesda, MdRobert A. WoodJohns Hopkins MedicineJennifer KimDepartment of Pediatrics, Division of Allergy & Immunology, Icahn School of Medicine at Mount Sinai, New York, NYKari C. NadeauDepartments of Medicine and Pediatrics, Sean N. Parker Center for Allergy and Asthma Research, Stanford School of Medicine, Stanford, CalifKirsi M. JärvinenDepartment of Pediatrics, Division of Allergy and Immunology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NYAlexander GrishinDepartment of Pediatrics, Division of Allergy & Immunology, Icahn School of Medicine at Mount Sinai, New York, NYRobert LindbladEMMES Corporation, Rockville, MdHugh A. SampsonDepartment of Pediatrics, Division of Allergy & Immunology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: [email protected]
2017en
Ochiq kirishYashil
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba